Insider buying last 90 days
No open-market insider purchases were filed for ENSG in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every ENSG insider filing, plotted on the chart in Gekko.Open ENSG in Gekko
NASDAQ: ENSG
Ensign (ENSG) Stock Analysis & Forecast
Sep 28 close
$176.36+1.18 (+0.7%)
Gekko Brief
AI summaryEnsign faces a series of securities law investigations this week, with multiple law firms including Kaplan Fox and Rosen Law Firm investigating potential violations following short-seller reports from June 2026 that raised allegations about business practices, regulatory compliance, and quality of care. Separately, the stock is noted as a momentum name and is set to go ex-dividend on September 30th, with a quarterly dividend of $0.0650 per share announced on September 18th.
The stock closes at $176.36, down against both its 50-day average of $176.51 and 200-day average of $181.84, with the 50-day sitting below the 200-day. The GekkoIndex reads 57.2, placing it in the Neutral zone. Price sits 11.2% above Gekko Fair Value of $158.54.
Over the next 20 trading days, the next earnings report lands on 2 November, 34 days out and beyond a typical holding window. No insider, Congress, or unusual options activity appears in their respective windows. Seasonality data shows the next 20 trading days from this point in the calendar averaged a 2.1% return across 5 years, with gains in 3 of them. Analyst consensus among 3 firms includes 2 buy and 1 hold ratings, with a consensus target of $220 and consensus upside of 24.7%. The ongoing legal investigations remain a background factor worth monitoring alongside these technical signals.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Ensign price vs fair value
Close $176.36200-day averageGekko Fair Value $158.54
Ensign quick facts
- Market cap
- $10.28B
- P/E ratio
- 27.5
- Forward P/E
- 20.7
- EPS, TTM
- $6.38
- Revenue, TTM
- $5.49B
- Profit margin
- 6.9%
- Dividend yield
- 0.15%
- Beta
- 0.69
- Volume
- 321,310 avg 353,760
- 1-year return
- +3.8%
- Typical daily move
- ±2.1%
- Typical 20-day move
- ±4.8%
- 50-day average
- $176.51
- 200-day average
- $181.84
- Next earnings
- Nov 2
- Shares outstanding
- 58.28M
Ensign swing-trade checklist
Ensign scores 2 supportive, 1 mixed and 2 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive1 mixed2 headwinds
- Trendheadwind
Below 50 and 200-day
Close $176.36 is below the 50-day ($176.51) and 200-day ($181.84) averages, and the 50-day is below the 200-day.
See the chart - GekkoIndexmixed
57.2, Neutral
Reading 57.2 is in the Neutral zone.
See the GekkoIndex - Fair valueheadwind
11.2% above
Price is 11.2% above Gekko Fair Value (more than 5% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 34 days
Next report Nov 2, 2026, 34 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitysupportive
+2.1% on average
From this point in the calendar, the next 20 trading days averaged +2.1% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Ensign stock chart and price history
Ensign closed at $176.36 on Sep 28, 2026, +3.8% over the past year, inside a 52-week range of $141.58 to $218.00.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +1.6%
- 3 months
- +11.5%
- 6 months
- −12.1%
- 1 year
- +3.8%
The full ENSG chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open ENSG in Gekko
Follow Ensign through every session
Put ENSG on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track ENSG in GekkoFree for 7 days. No credit card required.
About Ensign
Ensign works in post-acute healthcare, offering nursing care for people recovering from prolonged illness, managing ongoing health conditions, or needing elder care. It is known for combining medical treatment with everyday support such as housing, meal planning, and recreational activities for residents. Its services extend to rehabilitative therapies including physical, occupational, and speech therapy, as well as senior living facilities and mobile diagnostic offerings like X-rays, ultrasounds, and lab work.
The company runs through two divisions, Skilled Services and Real Estate. The Skilled Services arm covers the clinical and residential care work described above, along with sub-acute care and patient transport to and from homes or long-term facilities. The Real Estate arm involves leasing property. Together these divisions supported a network of 252 healthcare facilities located across thirteen U.S. states, including California, Texas, Arizona, and Washington, as of April 2022.
Ensign was founded in 1999 and is based in San Juan Capistrano, California. Its shares are listed on the NASDAQ under the ticker ENSG.
- Listed
- NASDAQ
- Sector
- Health services
- Industry
- Medical/Nursing services
- Website
- ensigngroup.net
Ensign GekkoIndex: the smart money zone
Ensign’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 57.2, in the Neutral zone, down 3.4 points over five sessions.
57.2Neutral
Down 3.4 points over five sessions, from the Accumulation zone.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 27 | +0.4% | +2.5% | ||
| Accumulation | 221 | +0.3% | +1.3% | ||
| Neutral (current zone) | 380 | +0.4% | +1.6% | ||
| Distribution | 43 | +0.4% | +1.1% | ||
| Selling | 1 | Too few readings yet | |||
Average ENSG share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the ENSG price, zone by zone.Track ENSG in Gekko
Is Ensign stock overvalued? Gekko Fair Value
Ensign trades 11.2% above Gekko Fair Value of $158.54, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Ensign shares are worth, recalculated every trading day.
$158.54
Gekko Fair Value, Sep 29, 2026
11.2% Overvalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open ENSG in Gekko
Ensign insider and Congress trading
No open-market insider purchases were filed for Ensign, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in ENSG were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for ENSG, plotted on the chart in Gekko.Open ENSG in Gekko
Buybacks
Ensign has been buying back its own shares.
- Latest authorization
- $100.0M, Jun 15, 2026
- Bought back, quarter ended Jun 30, 2026
- $40.96M
- As a share of market cap
- 0.40%
- Trailing four quarters
- $42.41M
From company filings.
Hedge funds and billionaires quarter ended Dec 31
1of the funds Gekko tracks holds ENSG.
1added0opened0trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko
Ensign earnings: next date and track record
Ensign reports on Nov 2, 2026 (34 days away), and beat the EPS estimate in 8 of its last 8 reports.
Next earnings report
Nov 2, 2026
34 days away
- EPS estimate
- $1.94
- Revenue estimate
- $1.51B
8 of 8reports beat the EPS estimate
±3.8%average move across the report
6 of 8reports followed by a gain
Share-price move across each report
Last earnings call, May 1, 2026 AI summary
- What they said
- Ensign Group reported Q1 2026 results with record same-store occupancy of 84.3% and transitioning occupancy of 85.1%. Same-store skilled revenue grew 9.6% and Medicare revenue increased 9.8% year-over-year. Sequential growth was seen across all skilled payers, with managed care and Medicare census rising 6.2% and 8.3% respectively from Q4. Management attributed performance to high-quality clinical outcomes driving increased patient trust and higher-acuity case mix.
- Guidance
- Management did not provide specific numerical guidance in this excerpt. However, leadership expressed confidence in continued strong occupancy and skilled mix trends, dismissing concerns about managed care slowdowns as inconsistent with their operational experience.
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| May 1, 2026 | $1.85 est $1.82 | $1.39B est $1.40B | −2.5% |
| Feb 11, 2026 | $1.82 est $1.75 | $1.36B est $1.37B | +5.1% |
| Oct 23, 2025 | $1.64 est $1.61 | $1.30B est $1.37B | +0.7% |
| Jul 24, 2025 | $1.59 est $1.55 | $1.23B est $1.22B | +7.8% |
| Apr 29, 2025 | $1.52 est $1.49 | $1.17B est $1.17B | +1.5% |
| Feb 5, 2025 | $1.49 est $1.48 | $1.13B est $1.13B | −6.5% |
| Oct 24, 2024 | $1.39 est $1.38 | $1.08B est $1.07B | +1.9% |
| Jul 25, 2024 | $1.32 est $1.30 | $1.04B est $1.02B | +4.5% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Ensign stock forecast and analyst price targets
Analysts’ average 12-month price target for Ensign is $220.00, +24.7% from the last close, from 3 firms rating the stock in the last 90 days.
$220.00consensus 12-month target, +24.7% from the last close
Now $176.36Avg $220.00
Low $210High $228
Each firm’s latest rating in the last 90 days: 3 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 22 | Oppenheimer | $210 | +19.1% |
| Jul 28 | Oppenheimer | $210 | +19.1% |
| Jul 28 | Truist Financial | — | — |
| Jul 27 | RBC Capital | $228 | +29.3% |
| Jul 22 | Oppenheimer | $210 | +19.1% |
+1.6%average 20-day move after past Neutral readings
+2.1%average move over the next 20 trading days in the last 5 years
±2.1%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Ensign seasonality: the next 20 trading days
Over the next 20 trading days from Sep 26, Ensign averaged +2.1% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.0% | 2 of 5 |
| Next 10 trading days | +0.4% | 3 of 5 |
| Next 15 trading days | +2.8% | 4 of 5 |
| Next 20 trading days | +2.1% | 3 of 5 |
| Next 30 trading days | +6.1% | 4 of 5 |
For scale, ENSG’s typical 20-trading-day move in either direction is about 4.8%.
Ensign market cap and key statistics
Ensign’s market cap is $10.28B, with a P/E ratio of 27.5 and revenue of $5.49B over the last twelve months.
Valuation
- Market cap
- $10.28B
- P/E ratio
- 27.5
- Forward P/E
- 20.7
- EPS, TTM
- $6.38
- Gekko Fair Value
- $158.54
Trading
- Volume
- 321,310
- Avg volume, 20 days
- 353,760
- 52-week high
- $218.00
- 52-week low
- $141.58
- Shares outstanding
- 58.28M
Financials
- Revenue, TTM
- $5.49B
- Profit margin
- 6.9%
- Return on equity
- 17%
- Quarterly earnings growth, YoY
- +16.7%
Risk and income
- Beta
- 0.69
- Typical daily move
- ±2.1%
- Typical 20-day move
- ±4.8%
- Dividend yield
- 0.15%
Ensign stock news this week
Coverage of Ensign this week reads negative: 0 positive, 2 neutral and 3 negative headlines.
- Here's Why Ensign Group (ENSG) is a Strong Momentum StockZacks Investment Research, Sep 28
- The Ensign Group, Inc. (ENSG) To Go Ex-Dividend on September 30thDefense World, Sep 28
- Kaplan Fox Investor Alert: The Ensign Group, Inc. (ENSG) Investigated for Possible Securities Law ViolationsNewsfile Corp, Sep 28
- Ensign Group Faces Growing Investor InvestigationsSTL.News, Sep 27
- ROSEN, A LEADING NATIONAL FIRM, Encourages The Ensign Group, Inc. Investors to Inquire About Securities Class Action Investigation - ENSGNewsfile Corp, Sep 27
- Kaplan Fox Urges The Ensign Group, Inc. (NASDAQ: ENSG) Investors to Contact the Firm Regarding a Securities InvestigationFinancialContent, Sep 25
Ensign peers
Ensign’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LHLabcorp | Accumulation | 3.9% below |
| GHGuardant Health | Neutral | 0.5% above |
| SOLVSolventum | Neutral | 16.4% below |
| EHCEncompass Health | Neutral | 7.6% above |
| DVADaVita | Accumulation | 15.9% below |
| BTSGBrightSpring Health Services | Accumulation | 7.4% below |
A peer links to its own page where one exists.
Ensign stock FAQ
What is Ensign’s market cap?
Ensign’s market cap is $10.28B at the Sep 28, 2026 close of $176.36, with 58.28M shares outstanding. The shares trade on a P/E ratio of 27.5.
What is the Ensign stock forecast?
The consensus analyst 12-month price target for Ensign is $220.00, +24.7% from the last close. Of the 3 firms that rated the stock in the last 90 days, 2 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Ensign stock overvalued or undervalued?
On Gekko’s estimate Ensign is overvalued: the Sep 28, 2026 close of $176.36 is 11.2% above Gekko Fair Value of $158.54. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Ensign report earnings next?
Ensign is expected to report on Nov 2, 2026 (34 days away). Analysts expect earnings of $1.94 per share on revenue of $1.51B. Ensign beat the earnings estimate in 8 of its last 8 reports, moving 3.8% on average across the report.
What is Ensign’s 52-week high and low?
Ensign’s 52-week high is $218.00 and its 52-week low is $141.58; it closed at $176.36 on Sep 28, 2026, +3.8% over the past year.
Is Ensign stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (earnings risk and seasonality), 1 as mixed (gekkoindex) and 2 as headwinds (trend and fair value). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Ensign the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.